Next-generation sequencing

Unravel the complexity of the genome with DNA-seq solutions

Whether you’re interested in detecting DNA variants or identifying known and novel RNA fusions, complex workflows, long turnaround times and limited samples can impede progress, increase costs and delay actionable data. Our high-performance DNA sequencing (DNA-seq) technologies are optimized to overcome such challenges so you can sequence GC-rich regions with confidence, identify low-frequency variants with precision and get the most out of low-quality or limited-input samples. If you need custom panels, our experts are on hand to help with intelligent panel design.
QIAseq Tumor Mutational Burden Panels
Redefine amplicon sequencing: Find the variant that matters with targeted DNA-seq

PCR duplicates, false positives and library bias can undermine the quality of your targeted sequencing data. Introduce precision and confidence into your workflow by adopting the digital DNA sequencing approach.

Our platform-agnostic, expertly curated, targeted DNA sequencing panels utilize unique molecular indices to ensure superior coverage of:

  • GC-rich genomic regions
  • Exonic regions of genes
  • Hotspots
  • SNPs
  • Intronic and promoter regions
Error or low-frequency mutation?

Targeted DNA sequencing with panels is a powerful approach to detect low-frequency variants. However, a major drawback is that all DNA fragments look exactly the same, making it almost impossible to distinguish sequencing errors and unique DNA molecules. This limits your ability to detect low-frequency DNA variants confidently. Not with QIAseq – all catalog and custom panels contain unique molecular indices, which tag the original DNA molecules and eliminate false reads due to PCR, polymerase and machine-read errors.

Next-generation sequencing
Next-generation sequencing
Access the most difficult regions of the genome

QIAseq products include optimized amplicon sequencing buffers and enzymology, allowing you to access the most difficult regions of the genome. The chemistry used in the QIAseq Targeted DNA panels and workflow is compatible with both regular and GC-rich genomic regions. Achieve 100% coverage for genes rich in GC content such as CEBPA and CCND1 using tiling methods.

Outstanding sequencing metrics

Uniformity: Standard panels typically achieve uniformity of 99.5% at 0.2x of mean coverage and 96% at 0.5x of mean coverage.

Sensitivity: Gain higher confidence in calling low-frequency DNA variants. Standard panels can obtain over 90% sensitivity for 1% NA12878 SNP and indel on A typical coding region with false positives of less than 15 per megabase region.

More multiplexing: Products from other suppliers offer 96 sample multiplexing. QIAseq does not stop there: 384 samples can be multiplexed using indices specific to QIAseq.

Featured success story

Dr. Barnaby Clark, Laboratory Lead for Precision Medicine at Kings College Hospital NHS Foundation Trust, discusses his experiences with targeted sequencing and, ultimately, the choice of NGS panels for his projects.
Dr. Fergus J Couch
"QIAseq panels are able to get into difficult regions of the genome because they utilize a single primer extension design strategy. Up to 1500 samples can be sequenced simultaneously."

Dr. Fergus Couch, Mayo Clinic


Genomic insights powered by QIAseq

QIAseq solutions are based on the following innovations to minimize bias and maximize genome coverage, uniformity and precision.

Reduce sample mix-up and maximize throughput

Unique Dual Indices (UDI) provide the highest level of process safety and ensure confidence in sequencing data by mitigating “index hopping” and misassignment of reads. UDIs allow you to maximize sequencing throughput for lower per-sample sequencing costs. The combination of both UMIs and UDIs means that QIAseq Targeted Panels provide an unprecedented level of accuracy.
Sample to disease insights in record time

One optimized exome sequencing pipeline with reduced turnaround times to get you from sample to standardized variant classification and interpretation.

Automatable and scalable exome sequencing with a single-day workflow

Examining the exome to identify disease-causing variants but worried about coverage uniformity due to GC composition?

Detect pathogenic variants with confidence, ease and efficiency with our scalable single-day, automation-compatible workflow. Based on hybrid capture technology, QIAseq Human Exome Kits ensure:

  • Highly sensitive variant calling of targets of >500 genes
  • Reduced sequencing costs per sample by 50%
  • A 40% decrease in overall turnaround time from sample to data

Seamless integration with QIAGEN CLC Genomics Workbench enables rapid variant calling and QCI Translational ensures accurate variant interpretation and disease-specific insights – without the burden of manual curation.

Capture a comprehensive view of the genome

Whole genome and hybrid capture sequencing provide a holistic view of the entire genome and unparalleled insights, but they can be time-and cost-intensive approaches. QIAseq solutions make these methodologies more accessible by maximizing per-sample data quality.

Benefit from:

  • Advanced chemistries for picogram sample input and fast, automatable protocols
  • Enzymatic DNA fragmentation – no need for expensive mechanical shearing equipment
  • Increased ligation efficiencies for high conversion rates and yields – no adapter-dimers
  • Uniform G/C representation from any organism
  • Convenient kit formats with included dual-barcoded adapters
QIAseq FX Library
Featured success story

Dr. Egbert Schulze from the Endocrinology and Nuclear Medicine Community Practice, Heidelberg, discusses how the all-enzymatic QIAseq FX workflow enabled uniform coverage and helped him achieve reliable sequencing results in his research.

Automate and accelerate your library prep
How can automating your NGS library prep benefit your lab?
Ultimate confidence in ultra-rare variant detection from cfDNA
Looking for those all-important but ultra-rare variants from cfDNA? With our QIAseq Targeted cfDNA Ultra Panels, you’ve struck gold. Our panels allow you to detect ultra-rare variants down to 0.1% variant allele frequency (VAF) from cfDNA using a streamlined, 8-hour workflow.
QIAseq cfDNA Ultra visual illustration
single cell teaser image
PCR-free, single-cell whole genome library prep with comprehensive coverage and high sequence fidelity
Are single cells or limited genomic DNA amounts limiting your ability to gain a deeper view of the genome? Explore how you can prepare whole genome libraries from single cells in <4 h using our single-cell DNA library prep kit. The PCR-free protocol eliminates bias, so you can confidently analyze aneuploidy, copy number and sequence variation in single cells from rare samples.
Deciphering microbial diversity

Metagenomic data are used to examine the species present in natural or healthy microbiomes, quantify the abundance of virulent or antibiotic resistance genes, or shed light on the causes, effects and future therapies for a variety of diseases. Whether you need PCR amplicon sequencing, whole-metagenomic analysis or 16S analysis of a DNA sample, QIAseq NGS solutions are designed to unravel the genomic complexity of your sample.

Water Microbiome
Take the shortcut – library normalization without quantification
Save time and ditch that traditional time-consuming library quantification method. With our QIAseq Normalizer Kit, you can easily pool libraries without the need for library quantification and still achieve qPCR-level accuracy. All it takes is 30 min.
Normalizer illustration main header

Webinar highlights

Enterprise Genomics Solutions
Combine unparalleled expertise and support with our high-performance QIAseq technologies. From panel design to analysis and beyond – our Enterprise Genomic Solutions simplify biomarker discovery to propel your research forward.
All photos taken prior to COVID-19